Table 2.
Baseline Characteristics of the Enrolled Patients (Full Analysis Set)
| Characteristics | TJP-008-2 (n=97) | TJP-008-1 (n=98) | 2LPEG (n=98) |
|---|---|---|---|
| Age, mean (range), yr | 48.0 (25–78) | 49.5 (22–75) | 45.5 (21–77) |
| Male sex, No. (%) | 35 (37.1) | 45 (45.9) | 41 (41.8) |
| BMI, mean±SD, kg/m2 | 24.16±2.91 | 24.44±2.86 | 24.09±2.68 |
| Screening colonoscopies, No. (%) | 28 (28.9) | 38 (38.8) | 43 (43.9) |
| Known renal and urinary disorders, No. (%) | 2 (2.1) | 1 (1.0) | 0 |
| Bladder diverticulum | 1 (1.0) | 0 | 0 |
| Chronic kidney disease | 0 | 1 (1.0) | 0 |
| Neurogenic bladder | 1 (1.0) | 0 | 0 |
TJP-008-2, TJP-008, administered as an evening/morning regimen; TJP-008-1, TJP-008, administered as a morning-only regimen; 2LPEG, 2 L polyethylene glycol with ascorbate; BMI, body mass index.